pubmed-article:17352768 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17352768 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:17352768 | lifeskim:mentions | umls-concept:C0021756 | lld:lifeskim |
pubmed-article:17352768 | lifeskim:mentions | umls-concept:C0243009 | lld:lifeskim |
pubmed-article:17352768 | lifeskim:mentions | umls-concept:C2698872 | lld:lifeskim |
pubmed-article:17352768 | lifeskim:mentions | umls-concept:C1522577 | lld:lifeskim |
pubmed-article:17352768 | lifeskim:mentions | umls-concept:C1561565 | lld:lifeskim |
pubmed-article:17352768 | lifeskim:mentions | umls-concept:C0392747 | lld:lifeskim |
pubmed-article:17352768 | lifeskim:mentions | umls-concept:C0439231 | lld:lifeskim |
pubmed-article:17352768 | lifeskim:mentions | umls-concept:C0439378 | lld:lifeskim |
pubmed-article:17352768 | lifeskim:mentions | umls-concept:C1516050 | lld:lifeskim |
pubmed-article:17352768 | lifeskim:mentions | umls-concept:C1552601 | lld:lifeskim |
pubmed-article:17352768 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:17352768 | pubmed:dateCreated | 2007-3-13 | lld:pubmed |
pubmed-article:17352768 | pubmed:abstractText | ESPRIT is a randomized trial comparing the clinical impact of interleukin (IL)-2 plus antiretrovirals vs antiretrovirals alone. Identification of factors that influence the relationship between IL-2 and CD4 count recovery will enable better personalization of treatment with IL-2 in HIV-1-positive individuals. The IL-2 induction phase consists of three dosing cycles over 6-8 months (7.5 MIU twice a day, for 5 days every 8 weeks). | lld:pubmed |
pubmed-article:17352768 | pubmed:language | eng | lld:pubmed |
pubmed-article:17352768 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17352768 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:17352768 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17352768 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17352768 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17352768 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17352768 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17352768 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17352768 | pubmed:month | Mar | lld:pubmed |
pubmed-article:17352768 | pubmed:issn | 1464-2662 | lld:pubmed |
pubmed-article:17352768 | pubmed:author | pubmed-author:GuoY EYE | lld:pubmed |
pubmed-article:17352768 | pubmed:author | pubmed-author:PhillipsAndre... | lld:pubmed |
pubmed-article:17352768 | pubmed:author | pubmed-author:KlimasNancyN | lld:pubmed |
pubmed-article:17352768 | pubmed:author | pubmed-author:WeissLaurence... | lld:pubmed |
pubmed-article:17352768 | pubmed:author | pubmed-author:LundgrenJens... | lld:pubmed |
pubmed-article:17352768 | pubmed:author | pubmed-author:StaszewskiSch... | lld:pubmed |
pubmed-article:17352768 | pubmed:author | pubmed-author:GazzardBrianB | lld:pubmed |
pubmed-article:17352768 | pubmed:author | pubmed-author:NeatonJames... | lld:pubmed |
pubmed-article:17352768 | pubmed:author | pubmed-author:RuxrungthamKi... | lld:pubmed |
pubmed-article:17352768 | pubmed:author | pubmed-author:AntunesFranci... | lld:pubmed |
pubmed-article:17352768 | pubmed:author | pubmed-author:LossoMarceloM | lld:pubmed |
pubmed-article:17352768 | pubmed:author | pubmed-author:ESPRIT... | lld:pubmed |
pubmed-article:17352768 | pubmed:author | pubmed-author:DaveyRickR | lld:pubmed |
pubmed-article:17352768 | pubmed:author | pubmed-author:LabriolaAnnA | lld:pubmed |
pubmed-article:17352768 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:17352768 | pubmed:volume | 8 | lld:pubmed |
pubmed-article:17352768 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17352768 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17352768 | pubmed:pagination | 112-23 | lld:pubmed |
pubmed-article:17352768 | pubmed:meshHeading | pubmed-meshheading:17352768... | lld:pubmed |
pubmed-article:17352768 | pubmed:meshHeading | pubmed-meshheading:17352768... | lld:pubmed |
pubmed-article:17352768 | pubmed:meshHeading | pubmed-meshheading:17352768... | lld:pubmed |
pubmed-article:17352768 | pubmed:meshHeading | pubmed-meshheading:17352768... | lld:pubmed |
pubmed-article:17352768 | pubmed:meshHeading | pubmed-meshheading:17352768... | lld:pubmed |
pubmed-article:17352768 | pubmed:meshHeading | pubmed-meshheading:17352768... | lld:pubmed |
pubmed-article:17352768 | pubmed:meshHeading | pubmed-meshheading:17352768... | lld:pubmed |
pubmed-article:17352768 | pubmed:meshHeading | pubmed-meshheading:17352768... | lld:pubmed |
pubmed-article:17352768 | pubmed:meshHeading | pubmed-meshheading:17352768... | lld:pubmed |
pubmed-article:17352768 | pubmed:meshHeading | pubmed-meshheading:17352768... | lld:pubmed |
pubmed-article:17352768 | pubmed:meshHeading | pubmed-meshheading:17352768... | lld:pubmed |
pubmed-article:17352768 | pubmed:meshHeading | pubmed-meshheading:17352768... | lld:pubmed |
pubmed-article:17352768 | pubmed:meshHeading | pubmed-meshheading:17352768... | lld:pubmed |
pubmed-article:17352768 | pubmed:meshHeading | pubmed-meshheading:17352768... | lld:pubmed |
pubmed-article:17352768 | pubmed:meshHeading | pubmed-meshheading:17352768... | lld:pubmed |
pubmed-article:17352768 | pubmed:year | 2007 | lld:pubmed |
pubmed-article:17352768 | pubmed:articleTitle | Predictors of CD4 count change over 8 months of follow up in HIV-1-infected patients with a CD4 count>or=300 cells/microL who were assigned to 7.5 MIU interleukin-2. | lld:pubmed |
pubmed-article:17352768 | pubmed:affiliation | Hvidovre University Hospital, DK-2650 Hvidovre, Denmark. z.fox@pcps.ucl.ac.uk | lld:pubmed |
pubmed-article:17352768 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:17352768 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:17352768 | pubmed:publicationType | Multicenter Study | lld:pubmed |
pubmed-article:17352768 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17352768 | lld:pubmed |